CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析

◆英語タイトル:CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8010339
◆発行会社(調査会社):GlobalData
◆発行日:2018年1月4日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:輸送・物流
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

CryoPort Inc (CYRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cryoport Inc (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials related to the shipment. It also offers SmartPak II condition monitoring system that provides information regarding the shipment including pressure, light, orientation, location, temperature, humidity and shock. Cryoport provides logistics consulting for supply chain optimization from the manufacturer to patient, staff training, software installation and site assessment. It offers services to bio-pharmaceutical institutions including contract manufacturers, labs, diagnostics, clinical trial centers; academic and research institutions; in-vitro fertility (IVF) industry and animal health market. Cryoport is headquartered in Irvine, California, the US.

CryoPort Inc Key Recent Developments

Nov 02,2017: Cryoport Revenue Up 52%; Driven by BioPharma
Aug 08,2017: Cryoport Revenue Up 52% for the Second Quarter of 2017, Driven by Biopharma
Jul 13,2017: Cryoport Continues to Strengthen Sales Team with Appointments of Colin Coffua as Vice President, Strategic Accounts and John Phillips as Executive Director, Consulting Services
Jun 07,2017: Cryoport Expands Agreement with Sanaria to Support Grant Awards with U.S. National Institutes of Health and U.S. Army
Mar 13,2017: Cryoport Revenue Continues to Climb, Reporting 53% Growth for the Quarter Ended December 31, 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
CryoPort Inc – Key Facts 5
CryoPort Inc – Key Employees 6
CryoPort Inc – Key Employee Biographies 7
CryoPort Inc – Major Products and Services 8
CryoPort Inc – History 9
CryoPort Inc – Company Statement 11
CryoPort Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
CryoPort Inc – Business Description 13
CryoPort Inc – SWOT Analysis 15
SWOT Analysis – Overview 15
CryoPort Inc – Strengths 15
CryoPort Inc – Weaknesses 17
CryoPort Inc – Opportunities 18
CryoPort Inc – Threats 19
CryoPort Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
CryoPort Inc, Recent Deals Summary 27
Section 4 – Company’s Recent Developments 28
Nov 02, 2017: Cryoport Revenue Up 52%; Driven by BioPharma 28
Aug 08, 2017: Cryoport Revenue Up 52% for the Second Quarter of 2017, Driven by Biopharma 30
Jul 13, 2017: Cryoport Continues to Strengthen Sales Team with Appointments of Colin Coffua as Vice President, Strategic Accounts and John Phillips as Executive Director, Consulting Services 32
Jun 07, 2017: Cryoport Expands Agreement with Sanaria to Support Grant Awards with U.S. National Institutes of Health and U.S. Army 33
Mar 13, 2017: Cryoport Revenue Continues to Climb, Reporting 53% Growth for the Quarter Ended December 31, 2016 34
Jan 17, 2017: Cryoport to Support ProMab Biotechnologies’ CAR-T Cell Preclinical Services 36
Section 5 – Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
CryoPort Inc, Key Facts 5
CryoPort Inc, Key Employees 6
CryoPort Inc, Key Employee Biographies 7
CryoPort Inc, Major Products and Services 8
CryoPort Inc, History 9
CryoPort Inc, Subsidiaries 12
CryoPort Inc, Key Competitors 20
CryoPort Inc, Ratios based on current share price 21
CryoPort Inc, Annual Ratios 22
CryoPort Inc, Annual Ratios (Cont...1) 23
CryoPort Inc, Interim Ratios 25
CryoPort Inc, Recent Deals Summary 27
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40

★海外企業調査レポート[CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • William Hill PLC:企業の戦略・SWOT・財務情報
    William Hill PLC - Strategy, SWOT and Corporate Finance Report Summary William Hill PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Skanray Technologies Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Skanray Technologies Pvt Ltd (Skanray) is a medical equipment manufacturing company that provides high frequency x-ray imaging systems, critical care devices, and primary healthcare and telemedicine compatible devices. The company’s product categories include defibrillator, ventilators, surg …
  • Medidata Solutions Inc (MDSO):企業の財務・戦略的SWOT分析
    Medidata Solutions Inc (MDSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Shunfeng International Clean Energy Ltd (1165):電力:M&Aディール及び事業提携情報
    Summary Shunfeng International Clean Energy Ltd (Shunfeng International), formerly Shunfeng Photovoltaic International Ltd is a renewable energy company that manufactures and markets solar photovoltaic products. The company’s products include monocrystalline silicon solar cells, polycrystalline sili …
  • Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuron Biopharma SA (NBP) is a biotechnology company that discovers and develops biosolutions. The company offers pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treatmen …
  • Dis-Chem Pharmacies Limited (DCP):企業の財務・戦略的SWOT分析
    Dis-Chem Pharmacies Limited (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Disco Corp (6146):企業の財務・戦略的SWOT分析
    Disco Corp (6146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mitsui Oil Exploration Co Ltd:企業の戦略的SWOT分析
    Mitsui Oil Exploration Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • University of Massachusetts Medical School:企業のM&A・事業提携・投資動向
    University of Massachusetts Medical School - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Massachusetts Medical School Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Pfizer Inc (PFE):医療機器:M&Aディール及び事業提携情報
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • Eskom Uganda Ltd:企業の戦略的SWOT分析
    Eskom Uganda Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a biotechnology company which focuses on research, development and commercialization of novel products that prevent and remove biofilm related infections in humans and animals. The company’s products include StrixNB and Vetradent water additive, oral spray, …
  • Revolution Lighting Technologies Inc (RVLT):企業の財務・戦略的SWOT分析
    Revolution Lighting Technologies Inc (RVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • SPX Corporation:企業の戦略・SWOT・財務分析
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Magnotta Winery Corporation:企業の戦略・SWOT・財務情報
    Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report Summary Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • OpGen Inc (OPGN)-製薬・医療分野:企業M&A・提携分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • MorphoSys AG (MOR)-製薬・医療分野:企業M&A・提携分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product include MOR208, MOR202, MOR103, MOR209/ES414, MOR106, and MOR107, among others. It drugs are used in the treatment of different types of canc …
  • PATRIZIA Immobilien AG:企業のM&A・事業提携・投資動向
    PATRIZIA Immobilien AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PATRIZIA Immobilien AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Amphastar Pharmaceuticals Inc (AMPH)-製薬・医療分野:企業M&A・提携分析
    Summary Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient (insulin API) products. The company’s product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆